Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus

Figure 3

Oral glucose tolerance, insulin response, and fraction A1c of the glycosylated hemoglobin in different groups to two months of treatment. (a–c) Independent insulin (I-I) model. (d–f) Insulin-requiring (I-R) model. The results shown are the average of 5 different experiments ± SEM. indicates significant difference from the control group group by ANOVA test with a Bonferroni post hoc test.